Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION (Tables)

v3.22.2
SHARE-BASED COMPENSATION (Tables)
 6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Schedule of summarizes share-based compensation expense
                               
    Three Months Ended June 30,     Six Months Ended June 30,  
    2022     2021     2022     2021  
Research and development   $ 1,169     $ 254     $ 2,135     $ 468  
Sales and marketing     1,197       196       2,279       336  
General and administrative     4,541       363       9,015       657  
Cost of sales     65       14       107       28  
Total share-based compensation   $ 6,972     $ 827     $ 13,536     $ 1,489  
Schedule of common stock options
                               
    Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life (Years)     Weighted-Average
Grant Date
Fair Value		  
Outstanding, December 31, 2021     5,489,492     $ 4.23       6.05     $ 2.27  
Granted     2,654,904       2.81       -       2.20  
Exercised     -       -       -       --  
Forfeited     (14,114 )     6.01       -       2.59  
Expired     (146,668 )     5.10       -       2.73  
Outstanding, June 30, 2022(a)     7,983,614     $ 3.74       7.06     $ 2.24  
Exercisable, June 30, 2022(b)     4,305,177     $ 3.98       5.21     $ 2.09  

 

  (a) The aggregate intrinsic value of all stock options outstanding as of June 30, 2022 was $1.9 million.

 

  (b) The aggregate intrinsic value of all vested/exercisable stock options as of June 30, 2022 was $0.9 million.
Schedule of Unvested Restricted Stock Units
               
    Number of Shares     Weighted Average Grant Date Fair Value  
             
Outstanding (nonvested), December 31, 2021     351,831     $ 9.63  
Granted     -       -  
Forfeited     -       -  
Outstanding (nonvested), June 30, 2022     351,831     $ 9.63  

 

As of June 30, 2022, there was $0.4 million of unrecognized compensation expense related to RSAs to be recognized over a weighted average period of 0.12 years.

 

Restricted Stock Units

 

As part of the consideration in the Business Combination, RSUs with respect to 1,750,000 shares of Common Stock were granted to the participants in Legacy Airspan’s MIP. For the RSUs granted to MIP Participants, the weighted average grant date fair value was $9.75 per RSU. The RSUs granted in connection with the MIP vest one year after the date of the grant.

 

The following table sets forth the activity for all RSUs:

 

    Number of
RSUs		     Weighted Average
Grant Date
Fair Value		  
Outstanding (nonvested), December 31, 2021     2,962,884     $ 8.60  
Granted     3,552,935       2.93  
Forfeited     (108,500 )     6.94  
Outstanding (nonvested), June 30, 2022     6,407,319     $ 5.49